spacer
home > pmps > winter 2019 > embracing spray drying strategies
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Embracing Spray Drying Strategies

Orally inhaled drug products have several therapeutic advantages over other dosage forms − most notably, a more direct delivery to the central nervous system. By their very nature, they avoid the first pass effect through the liver, for both regional as well as systemic delivery. This allows drug developers to formulate delivery strategies that reduce the dosage strength and limit the risk of adverse side effects. While pharmaceutical companies have long recognised the potential of inhalation products, many are starting to explore development techniques such as spray drying in more depth.

This article will outline the benefits of using respirable-engineered dry powder for inhalation products, as well as discussing how the new 505 (b) (2) application route for faster approval of new formulations that use existing APIs is a suitable pathway to getting these products to market quickly and efficiently.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
5
     

There are no comments in regards to this article.

spacer
Aditya R Das PhD, MBA is Director of Business Development at Recipharm and is focussed on inhalation drug product development and commercialisation for global clients. He is responsible for coordinating the interface between client needs and external services and capabilities to facilitate optimal product development and global registration. Aditya has over 25 years’ experience working in combination biopharmaceutical product development, including pulmonary, transdermal, intravenous, implanted, and oral drug delivery therapeutic strategies and is an inventor on eight issued patents. He has a PhD in chemical engineering, an MBA from the University of California, US, an MS degree in chemical engineering from Carnegie Mellon University, US, and a BS degree in chemical engineering from the University of New Hampshire, US.
spacer
Aditya R Das PhD, MBA
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Cambridge Sensotec (manufacturers of Dynascan) obtains new ISO accreditation

On the 30th May 2019, Cambridge Sensotec proudly achieved ISO 9001:2015 accreditation under the BSI (British Standards Institution). Cambridge Sensotec Ltd now joins 1.3 million companies across 112 countries worldwide that hold this prestigious certificate.
More info >>

White Papers

Six Strategies to Stretch Your Limited Drug Supply for Clinical Studies

PCI Pharma Services

Bringing a new drug to market can be a heavy financial burden on any pharmaceutical company. It has become even more burdensome over the last several years as the industry pushes the boundaries of innovation. This is because newer, often more-complex therapies not only increase risk in drug development but also drive costs even higher. A recent analysis of the investment needed to develop a new prescription medicine shows the total cost can be as high as $2.6 billion (1). That number becomes even more staggering when you consider the fact that only about 12 percent of drug candidates that make it to Phase I testing are eventually approved by the FDA (2). The investment companies lose as a result may be too devastating to their bottom line to ever recover.
More info >>

 
Industry Events

FlyPharma Europe

22-23 October 2019, Copenhagen, Denmark

The FlyPharma Conference Europe 2019 is aimed at forward-thinking individuals and businesses that are ready to uncover the potential in their pharma supply chain. The event offers an interactive platform to discuss current and future challenges within pharma and cargo, with topics including market trends, cold chain innovations, latest regulatory demands, security technology, and how to encourage collaboration between supply chain players. There will be plenty of networking opportunities, including a complimentary evening networking event, where delegates can meet and catch up with senior and executive pharma and cargo professionals – gaining strong, new industry contacts and building on existing ones.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement